In lytic cancers (i.e., multiple myeloma or breast cancer), bone colonizing tumor cells secrete factors that promote osteoclastogenesis (i.e., PTHRP, IL6, RANKL, and M-CSF), tilting the balance in bone remodeling towards bone resorption [15,16,17,18]. Here, TNFSF11 is linked to neoplasm.